Fulgent
focuses on developing and commercializing novel formulations of anti-cancer therapeutics... Read moreFulgent
focuses on developing and commercializing novel formulations of anti-cancer therapeutics... Read more
Chairman & CEO
Ming Hsieh
News
Apr 21, 2025
Yahoo
Fulgent: Fulgent Genetics Inc (FLGT) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid ...
Apr 10, 2025
Yahoo
Fulgent: Fulgent to Announce First Quarter 2025 Financial Results on Friday, May 2, 2025
Mar 20, 2025
Seeking Alpha
Fulgent: Fulgent Genetics: Undervalued, CFO Buying, And Promising Drug Candidates Make It A Buy
Feb 28, 2025
Owler
Fulgent Genetics, Inc.: Fulgent's revenue changed from $277.76M in Sep 2024 to $283.47M in Dec 2024
Feb 28, 2025
Zacks
Fulgent: Fulgent Genetics, Inc. (FLGT) Q4 Earnings and Revenues Beat Estimates
Feb 28, 2025
Seeking Alpha
Fulgent: Fulgent Genetics Non-GAAP EPS of $0.04 beats by $0.16, revenue of $76M beats by $1.14M
Feb 06, 2025
Yahoo
Fulgent: Fulgent to Announce Fourth Quarter and Full Year 2024 Financial Results on Friday, February 28, 2025
Feb 05, 2025
Marketscreener
Fulgent: Foundation Medicine to Launch Hereditary Germline Tests, FoundationOneGermline and FoundationOneGermline More, in the United States Through a Partnership with Fulgent Genetics
Dec 24, 2024
Seeking Alpha
Fulgent: Fulgent Genetics: High Insider Ownership Supports Asymmetric Upside
Nov 09, 2024
Yahoo
Fulgent: Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline
Fulgent Competitors
1
2
3
4
5
6
7
8
9
10